Record Display for the EPA National Library Catalog


Main Title Cancer Risk-Specific Dose Estimate for 2,3,7,8-TCDD: Appendices A through F.
CORP Author Environmental Protection Agency, Washington, DC. Office of Health and Environmental Assessment.
Year Published 1988
Stock Number PB88-231212
Additional Subjects Toxicity ; Carcinogens ; Malignant neoplasms ; Hazardous materials ; Dosage ; Chlorine organic compounds ; Epidemiology ; Reproduction(Biology) ; Toxicology ; Cancer ; Toxic substances ; Risk assessment ; TCDD ; Dioxin/tetrachloro-dibenzo ; Health risks ; CAS 1746-01-6 ; Reference materials
Library Call Number Additional Info Location Last
NTIS  PB88-231212 Some EPA libraries have a fiche copy filed under the call number shown. 07/26/2022
Collation 270p
The draft report reexamines the scientific basis and methods used by the U.S. Environmental Protection Agency (EPA) for estimating the cancer potency of 2,3,7,8-tetrachlorodibenzo-p-dioxin (2,3,7,8-TCDD). It focuses on the hazard identification and dose-response assessment for the potential human carcinogenicity of this chemical. The objective of the report is to determine if EPA's 1985 cancer risk assessment for polychlorinated dibenzo-p-dioxins should be modified in light of recent data, alternative risk assessment methods, or alternative interpretations of data on the chemical. The draft report concludes that (1) the 1985 assessment that associates a 0.006 pk/kg/day dose with a plausible upper bound increased cancer risk of one in a million 10 to the -6 power should be reconsidered, and (2) a change to a 0.1 pg/kg/day dose as a plausible upper bound associated with an increased lifetime risk of one in a million is consistent with the available data and theories, and represents a reasonable science policy for the Agency. Appendices A through F to the document contain important background information on a broad range of issues related to 2,3,7,8-TCDD including quantitative implications (A), epidemiology (B and D), reproductive and developmental toxicity (C), immunotoxicity (E), and mechanisms of action (F).